Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease (vol 117, pg 942, 2021)

Liang Yan

首页> 外文期刊>Cardiovascular Research >Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease (vol 117, pg 942, 2021)

【24h】

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease (vol 117, pg 942, 2021)

机译：Rivaroxaban Plus Appirin在患有慢性冠状动脉或外周动脉疾病的妇女和男性的疗效和安全性（Vol 117，PG 942,2021）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cardiovascular Research》 |2021年第6期|共1页
作者
Liang Yan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial [J] . Jun-Bo Ge, Ying-Wu Liu, Sheng-Huang Wang, 中华医学杂志（英文版） . 2021,第002期
2. Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study [J] . Ru Liu, Run-Lin Gao, Jin-Qing Yuan, 中华医学杂志（英文版） . 2017,第014期
3. Can "Hybrid stent implantation" improve long-term safety without adversely affecting efficacy when treating multilesion coronary artery disease in the drug-eluting stent era? [J] . ZHANG Dong, XU Bo, DOU Ke-fei, 中华医学杂志（英文版） . 2013,第009期
4. The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis [J] . Ying XUE, Hong-yi WU, Xiang-Qun XIE, 中国药理学报：英文版 . 2018,第002期
5. Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease [J] . Liang Yan, Zhu Jun, Liu Lisheng, Cardiovascular Research . 2021,第3期

机译：Rivaroxaban Plus Aspirin在患有慢性冠状动脉或外周血疾病的男性中的疗效和安全性
6. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease The COMPASS Trial [J] . Branch Kelley R., Probstfield Jeffrey L., Eikelboom John W., Circulation: An Official Journal of the American Heart Association . 2019,第7期

机译：Rivaroxaban有或没有阿司匹林患者心力衰竭和慢性冠状动脉或外周动脉疾病指南针试验
7. Synergistic influence of rivaroxaban on inflammation and coagulation biomarkers in patients with coronary artery disease and peripheral artery disease on aspirin therapy [J] . Future cardiology . 2020,第2期

机译：蓖麻毒素对冠状动脉疾病患者炎症和凝血生物标志物对阿司匹林疗法的协同影响
8. Noninvasive assessment of chronic coronary artery disease by MsCT: Coronary artery calcification and its relation to systolic function [C] . Burazor I, Todorovic L., Susak S. World Congress on Heart Disease . 2011

机译：MSCT：冠状动脉钙化慢性冠状动脉疾病的非侵蚀性评估及其与收缩功能的关系
9. Life Course Evaluation of a Plant-Centered Diet and Risk of Type 2 Diabetes, Weight Gain, Cardiovascular Diseases, All-Cause Mortality, and Markers of Chronic Kidney Disease: The Coronary Artery Risk Development in Young Adults (Cardia) Cohort [D] . Choi, Yuni. 2021

机译：生命课程评估植物中心的饮食和2型糖尿病风险，体重增加，心血管疾病，慢性肾病的全因死亡率和标志性：年轻成年人的冠状动脉风险发展（Cardia）队列
10. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease [O] . Kelley R. Branch, Jeffrey L. Probstfield, John W. Eikelboom, -1

机译：患有或未患有阿司匹林的心力衰竭和慢性冠状动脉或周围动脉疾病患者使用利伐沙班
11. Corrigendum to: Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease [O] . 2020

机译：勘犯：rivaroxaban加上阿司匹林在患有慢性冠状动脉或外周动脉疾病的妇女和男性的疗效和安全性
12. Risk Indicators in Coronary Cardiac Disease and Occlusive Disease of the Peripheral Arteries: Comparative Coronary and Peripheral Angiography - Total Angiography - in 160 Patients [R] . Roth, H. 1982

机译：冠状动脉心脏病和外周动脉闭塞性疾病的风险指标：比较冠状动脉和外周血管造影 - 总血管造影 - 160名患者

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease (vol 117, pg 942, 2021)

著录项

相似文献

相关主题

期刊订阅